Xspray Pharma has now completed the population pharmacokinetic (PopPK) modeling that constitutes key regulatory documentation ...

Pharmaceutical and personal care products (PPCPs) have been the focus of increasing concern in recent decades due to their ubiquity in the environment and potential risks. Out-of-date PPCPs are ...

UPPSALA, SE / ACCESS Newswire / July 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) invites investors, analysts, and media to a webcast presentation of the second quarter report for ...

OncoZenge Appoints Tuulikki Lindmark as Head of CMC in Phase 3 Sponsor TeamOncoZenge AB (publ) ("OncoZenge" or "the Company") announces today that the sponsor team for the phase 3 project with ...

Elon Musk's xAI has secured a controversial air permit for its Memphis AI hub, escalating a legal battle with the NAACP and ...

STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agoni ...

www.vicorepharma.com This information is information that Vicore Pharma Holding is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for ...

“Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock gained on optimism for the launch of its new drug Journavx, a non-opioid painkiller for acute pain and the first new class of pain ...

On this week’s episode of "The Top Line," Fierce Pharma’s Fraiser Kansteiner sits down with Francis to talk about the progress made so far on Teva’s “Pivot to Growth” strategy and what ...